Thomas J Greene

Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults

Samit R. Joshi, Mark Johnson, M. Lataillade, 2021, British journal of clinical pharmacology.

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

Samit R. Joshi, A. S. Krishnatry, G. Ferron-Brady, 2020, Pharmacology research & perspectives.

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women

Samit R. Joshi, Mark Johnson, M. Lataillade, 2021, British Journal of Clinical Pharmacology.